U-M gastroenterologists earn nation’s top awards for care, leadership
AGA presents Chung Owyang, M.D., with its highest honor for lifelong achievement, Grace H. Elta, M.D., is distinguished clinician
News: Digestive Health + Liver Disease
The Brain-Gut Connection: A Link between Depression and common hospital-acquired infection
Depression, being widowed and living alone increase risk of serious hospital-acquired infection.
Drug may relieve irritable bowel syndrome symptoms
A drug studied by gastroenterologists at the University of Michigan Health System may offer relief for symptoms of irritable bowel syndrome. In clinical trials patients showed improvement in abdominal pain and discomfort, cramping and bloating.
U-M hospital care is the best in the state and among the best in the nation, says new ranking
The University of Michigan Hospitals and Health Centers offer the best care in Michigan and some of the nation’s best care, according to a new ranking from U.S. News & World Report.
New guidelines help protect the hearts of those waiting for kidney and liver transplants
As thousands of Americans await a life-saving kidney or liver transplant, medical teams are paying close attention to another organ: their hearts.
Caring for patients with fecal incontinence costs more than $4,000 per person each year
Care for patients with fecal incontinence costs $4,110 per person for both medical and non-medical costs like loss of productivity, according to new research from the University of Michigan.
Serious complication of GI procedure can often be avoided with single dose medication
A study led by U-M gastroenterologists shows a simple anti-inflammatory drug can prevent post-ERCP pancreatitis, a painful complication that can follow the procedure to examine the digestive tract.
Greenview Foundation supports hepatitis C research at the University of Michigan
The Greenview Foundation announces a grant to suppport hepatitis C research at the University of Michigan Health System.
Combination of oral drugs suppresses common type of hepatitis C, according to University of Michigan-led research
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
Kidney failure risk higher for liver transplant patients following allocation policy change
U-M research shows the risk for kidney failure among liver transplant recipients is higher following a policy change in 2002 that altered how liver transplant allocation is decided.
High rates of disability and health care use found in older Americans with cirrhosis
Older patients with cirrhosis have significant functional disability, require twice the amount of informal caregiving, and contribute added strain on the health care system, according to U-M research.
Holiday tip sheet from the University of Michigan Health System
Reporters, producers and editors, here is our holiday gift to you: Story ideas that relate to the holidays, and some evergreen ideas that can help you fill the newspaper or broadcast during the slow news month ahead.
Transplant candidates seek best quality livers, even if it means waiting longer
Liver transplantation candidates want to be involved in decisions regarding quality of the donor organ, and many are reluctant to accept organs with a higher risk of failure, according to research by U-M physicians and experts.
U-M beats Ohio State twice, in life-saving donation challenges for blood and organs
U-M defeated Ohio State twice this week, even before taking the field for the big game, signing up more people to the state's organ donor list and collecting more pints of blood in two annual challenges.
UM-UMHS Hockey Int.mp3
Listen to Dr. Pinsky as he discusses how to live a heart-healthy life.
DNA from common stomach bacteria minimizes effects of colitis, U-M study says
DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice
UM-UMHS Hockey Int.mp3
Listen to Dr. Pinsky as he discusses how to live a heart-healthy life.
Hepatitis B virus re-emerges with long-term nucleoside analog treatment
A rebound of the Hepatitis B virus is common in patients receiving nucleoside analogs for chronic hepatitis but nearly 40% of the rebounds or virological breakthroughs (VBTs) were not related to antiviral drug resistance.
Antibiotic treatment effective for common gastrointestinal disorder
Millions of people in the United States suffer from irritable bowel syndrome, but new research indicates a drug therapy could offer long-lasting relief. William Chey, M.D., professor in the Department of Internal Medicine was among the researchers who studied the drug rifaximin's effects on IBS patients. The research will be published in the New England Journal of Medicine Jan. 6.